ClinicalTrials.Veeva

Menu

Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients with Bifid Median Nerve?

B

Beylikduzu State Hospital

Status

Completed

Conditions

Carpal Tunnel Syndrome

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06657612
BeylikduzuStateH6

Details and patient eligibility

About

The aim of this study is to evaluate the short-term efficacy of ultrasound-guided corticosteroid injection in patients with and without bifid median nerve.

Full description

Twenty-five patients with bifid median nerve and twenty-five patients without bifid median nerve, aged 18-65, who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital, diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies, and who received ultrasound-guided corticosteroid injection, will be included in our study. Patients identified as having a bifid median nerve during the injection will be noted and invited for a follow-up at the 1st month to assess their pain and functional status. The same follow-up visit will be conducted for an equal number of age- and gender-matched patients without bifid median nerve who received the injection. At the end of the study, the 1-month efficacy of the injection in both groups will be evaluated. Patients who agree to participate in the study will be asked to complete the Visual Analog Scale (VAS), the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), and the Quick Disabilities of the Arm, Shoulder, and Hand Questionnaire (Quick-DASH) before the injection. They will then be invited for a follow-up visit at the 1st month, where the VAS, BCTQ, and Quick-DASH will be administered again.

Enrollment

50 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18-65.
  • Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies conducted within the last 6 months.
  • Scheduled for ultrasound-guided corticosteroid injection.
  • Patients who have agreed to participate in the study.

Exclusion criteria

  • Diagnosis of any other condition that could cause neuropathic symptoms, such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
  • Previous history of injection or surgery for carpal tunnel syndrome
  • Patients who refuse to participate in the study.

Trial design

50 participants in 2 patient groups

Bifid median nerve
Description:
Patients (diagnosed with carpal tunnel syndrome) with bifid median nerve
Treatment:
Other: No intervention
Control group
Description:
Patients (diagnosed with carpal tunnel syndrome) with normal median nerve
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Büşra Şirin Ahısha

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems